CL2015003333A1 - Vacunas de e1e2 del vhc y métodos de uso - Google Patents
Vacunas de e1e2 del vhc y métodos de usoInfo
- Publication number
- CL2015003333A1 CL2015003333A1 CL2015003333A CL2015003333A CL2015003333A1 CL 2015003333 A1 CL2015003333 A1 CL 2015003333A1 CL 2015003333 A CL2015003333 A CL 2015003333A CL 2015003333 A CL2015003333 A CL 2015003333A CL 2015003333 A1 CL2015003333 A1 CL 2015003333A1
- Authority
- CL
- Chile
- Prior art keywords
- vhc
- vaccines
- methods
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361823712P | 2013-05-15 | 2013-05-15 | |
| US201361887229P | 2013-10-04 | 2013-10-04 | |
| PCT/IB2014/001972 WO2015132619A1 (en) | 2013-05-15 | 2014-05-15 | E1e2 hcv vaccines and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015003333A1 true CL2015003333A1 (es) | 2016-09-30 |
Family
ID=54054625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015003333A CL2015003333A1 (es) | 2013-05-15 | 2015-11-13 | Vacunas de e1e2 del vhc y métodos de uso |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20210145963A9 (https=) |
| EP (2) | EP3689375A1 (https=) |
| JP (5) | JP2016520077A (https=) |
| CN (2) | CN105263517B (https=) |
| AU (3) | AU2014385320B2 (https=) |
| CA (1) | CA2909586C (https=) |
| CL (1) | CL2015003333A1 (https=) |
| WO (1) | WO2015132619A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4491735A3 (en) * | 2015-10-08 | 2025-04-16 | The Governors of the University of Alberta | Hepatitis c virus e1/e2 heterodimers and methods of producing same |
| AU2017332854B2 (en) | 2016-09-21 | 2024-11-14 | The Governors Of The University Of Alberta | Hepatitis C virus immunogenic compositions and methods of use thereof |
| WO2018068132A1 (en) | 2016-10-11 | 2018-04-19 | The Governors Of The University Of Alberta | Hepatitis c virus immunogenic compositions comprising as an adjuvant a cyclic dinucleotide or an archaeosome and methods of use thereof |
| EP3765075A4 (en) * | 2018-03-16 | 2021-12-08 | The Governors of the University of Alberta | HEPATITIS C VIRUS PEPTIDE COMPOSITIONS AND METHOD OF USING THEREOF |
| WO2025222304A1 (en) * | 2024-04-26 | 2025-10-30 | The Governors Of The University Of Alberta | Hcv genotype3 e2 envelope protein for neutralizing infectivity of hcv strains |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| GB8815795D0 (en) | 1988-07-02 | 1988-08-10 | Bkl Extrusions Ltd | Glazing bead |
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| CA2138997C (en) | 1992-06-25 | 2003-06-03 | Jean-Paul Prieels | Vaccine composition containing adjuvants |
| US5776468A (en) | 1993-03-23 | 1998-07-07 | Smithkline Beecham Biologicals (S.A.) | Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| EP1167379A3 (en) | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| AU3241095A (en) | 1994-07-29 | 1996-03-04 | Chiron Corporation | Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| GB9513261D0 (en) | 1995-06-29 | 1995-09-06 | Smithkline Beecham Biolog | Vaccines |
| ATE292980T1 (de) | 1996-10-11 | 2005-04-15 | Univ California | Immunostimulierende oligonucleotidekonjugate |
| WO1998037919A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
| DK1005368T3 (da) | 1997-03-10 | 2010-01-04 | Ottawa Hospital Res Inst | Anvendelse af nukleinsyrer, der indeholder ikke-metyleret CpG dinukleotid i kombination med alun som hjælpestoffer |
| DE69841015D1 (de) | 1997-05-06 | 2009-09-10 | Novartis Vaccines & Diagnostic | Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2 |
| EP1003531B1 (en) | 1997-05-20 | 2007-08-22 | Ottawa Health Research Institute | Processes for preparing nucleic acid constructs |
| EP1003850B1 (en) | 1997-06-06 | 2009-05-27 | The Regents of the University of California | Inhibitors of dna immunostimulatory sequence activity |
| GB9712347D0 (en) | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
| AU1145699A (en) | 1997-09-05 | 1999-03-22 | Smithkline Beecham Biologicals (Sa) | Oil in water emulsions containing saponins |
| US6303114B1 (en) | 1998-03-05 | 2001-10-16 | The Medical College Of Ohio | IL-12 enhancement of immune responses to T-independent antigens |
| WO1999052549A1 (en) | 1998-04-09 | 1999-10-21 | Smithkline Beecham Biologicals S.A. | Adjuvant compositions |
| GB9817052D0 (en) | 1998-08-05 | 1998-09-30 | Smithkline Beecham Biolog | Vaccine |
| KR100629028B1 (ko) | 1998-10-16 | 2006-09-26 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 애쥬번트 시스템 및 백신 |
| ATE459373T1 (de) | 1999-03-19 | 2010-03-15 | Glaxosmithkline Biolog Sa | Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae |
| PT1187629E (pt) | 1999-04-19 | 2005-02-28 | Glaxosmithkline Biolog Sa | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador |
| HUP0202885A3 (en) | 1999-09-24 | 2004-07-28 | Smithkline Beecham Biolog | Vaccines |
| TR200200777T2 (tr) | 1999-09-24 | 2002-09-23 | Smithkline Beecham Biologicals S.A. | Polioksietilen alkil eteri veya esteriyle en az bir iyonik olmayan yüzey aktif maddeli adjuvant. |
| SK15762003A3 (sk) * | 2001-06-29 | 2005-01-03 | Chiron Corporation | Kompozícia vakcíny HCV E1E2 |
| US7348011B2 (en) * | 2005-06-10 | 2008-03-25 | Sudershan Biotech Ltd. | Hepatitis C virus vaccine |
| WO2007041432A2 (en) * | 2005-09-30 | 2007-04-12 | Novartis Vaccines And Diagnostics, Inc. | Cross-neutralization of hcv with recombinant proteins |
| US8603468B2 (en) * | 2007-11-06 | 2013-12-10 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Neutralization of HCV |
| WO2014060851A2 (en) * | 2012-10-05 | 2014-04-24 | The Governors Of The University Of Alberta | Hepatitis c virus immunogenic compositions and methods of use thereof |
-
2014
- 2014-05-15 JP JP2016513459A patent/JP2016520077A/ja not_active Withdrawn
- 2014-05-15 EP EP19215826.9A patent/EP3689375A1/en not_active Withdrawn
- 2014-05-15 AU AU2014385320A patent/AU2014385320B2/en active Active
- 2014-05-15 CA CA2909586A patent/CA2909586C/en active Active
- 2014-05-15 CN CN201480027001.3A patent/CN105263517B/zh active Active
- 2014-05-15 CN CN202110252076.3A patent/CN112999344A/zh active Pending
- 2014-05-15 EP EP14884476.4A patent/EP2996718B1/en active Active
- 2014-05-15 US US14/783,699 patent/US20210145963A9/en not_active Abandoned
- 2014-05-15 WO PCT/IB2014/001972 patent/WO2015132619A1/en not_active Ceased
-
2015
- 2015-11-13 CL CL2015003333A patent/CL2015003333A1/es unknown
-
2019
- 2019-05-08 JP JP2019087976A patent/JP2019142962A/ja not_active Withdrawn
-
2020
- 2020-01-10 AU AU2020200216A patent/AU2020200216A1/en not_active Abandoned
-
2021
- 2021-01-08 JP JP2021001926A patent/JP2021059596A/ja active Pending
-
2022
- 2022-02-04 AU AU2022200747A patent/AU2022200747A1/en not_active Abandoned
- 2022-03-23 US US17/702,231 patent/US20230098265A1/en not_active Abandoned
- 2022-08-31 JP JP2022137454A patent/JP2022172244A/ja active Pending
-
2023
- 2023-11-27 US US18/520,057 patent/US20240316186A1/en active Pending
-
2024
- 2024-08-07 JP JP2024130501A patent/JP2024156917A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240316186A1 (en) | 2024-09-26 |
| HK1216395A1 (en) | 2016-11-11 |
| JP2022172244A (ja) | 2022-11-15 |
| US20210145963A9 (en) | 2021-05-20 |
| WO2015132619A1 (en) | 2015-09-11 |
| JP2024156917A (ja) | 2024-11-06 |
| US20230098265A1 (en) | 2023-03-30 |
| CN112999344A (zh) | 2021-06-22 |
| JP2019142962A (ja) | 2019-08-29 |
| US20160067332A1 (en) | 2016-03-10 |
| AU2014385320A1 (en) | 2015-11-12 |
| EP2996718A1 (en) | 2016-03-23 |
| JP2016520077A (ja) | 2016-07-11 |
| EP2996718B1 (en) | 2020-01-15 |
| AU2020200216A1 (en) | 2020-02-06 |
| JP2021059596A (ja) | 2021-04-15 |
| CN105263517A (zh) | 2016-01-20 |
| AU2014385320B2 (en) | 2019-10-10 |
| CA2909586C (en) | 2021-08-31 |
| EP2996718A4 (en) | 2017-06-21 |
| AU2022200747A1 (en) | 2022-02-24 |
| CA2909586A1 (en) | 2015-09-11 |
| CN105263517B (zh) | 2021-03-26 |
| EP3689375A1 (en) | 2020-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200041I1 (hu) | Anti-CD3 antitestek és alkalmazási eljárások | |
| IL280155A (en) | Anti- SIGLEC-8 antibodies and methods of using them | |
| CL2016001102A1 (es) | Anticuerpos anti-claudina novedosos y métodos de uso. | |
| IL251970B (en) | Anti-cd79b antibodies and methods of use | |
| CL2016000251A1 (es) | Anticuerpos anti-activina y usos de los mismos | |
| HUE059701T2 (hu) | Antitestek és felhasználási módszerek | |
| IL242394B (en) | Cenicriviroc compositions and methods of making and using the same | |
| CL2016002462A1 (es) | Anticuerpos anti-ox40 y métodos de uso | |
| HUE051982T2 (hu) | Anti-alfa-szinuklein antitestek és alkalmazási eljárások | |
| PL3215532T3 (pl) | Przeciwciała anty-TIM3 i sposoby ich zastosowania | |
| SI3258951T1 (sl) | Anti-pvrig protitelesa in metode uporabe | |
| HRP20170840T1 (hr) | Supstituirani ksantini i metode njihove uporabe | |
| PL3623943T3 (pl) | Urządzenie przenośne i sposób ograniczania korzystania z urządzenia przenośnego | |
| CL2018000708A1 (es) | Fitasas modificadas y métodos de uso | |
| CO7000747A2 (es) | Anticuerpos anti-lrp5 y métodos de uso | |
| SMT201600069B (it) | Composizioni comprendenti 15-hepe e metodi d’uso delle stesse | |
| HUE053033T2 (hu) | Hidrolázoknak ellenálló kapszidokat alkalmazó készítmények és eljárások | |
| EP2983661C0 (en) | OXABICYCLOHEPTANE AND OXABICYCLOHEPTENE FORMULATIONS | |
| CL2016000235A1 (es) | Inhibidores de rorc2 y sus métodos de uso | |
| IL244590A0 (en) | Anti-epcam antibodies and methods of use | |
| CR20180296A (es) | ANTICUERPOS ANTI-HtrA1 Y MÉTODOS DE USO | |
| CO6940375A2 (es) | Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo | |
| EP2989432C0 (en) | IMAGING APPARATUS AND METHOD | |
| DK2969005T3 (da) | Attenuerede influenzavira og -vacciner | |
| BR112016004943A2 (pt) | aparelho médico e uso |